Patents by Inventor Hong-Nerng Ho

Hong-Nerng Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating non-compaction cardiomyopathy
    Patent number: 11690822
    Abstract: A method for treating a subject suffering from non-compaction cardiomyopathy (NCC), by administering to the subject suffering from NCC a pharmaceutical composition having a therapeutically effective amount of a EZH2 downregulator including the statin.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: July 4, 2023
    Assignees: EXCELSIOR PHARMATECH LABS, NATIONAL TAIWAN UNIVERSITY
    Inventors: Wen-Pin Chen, Mei-Hwan Wu, Hong-Nerng Ho
  • METHOD FOR TREATING NON-COMPACTION CARDIOMYOPATHY
    Publication number: 20210220327
    Abstract: A method for treating a subject suffering from non-compaction cardiomyopathy (NCC), by administering to the subject suffering from NCC a pharmaceutical composition having a therapeutically effective amount of a EZH2 downregulator including the statin.
    Type: Application
    Filed: May 23, 2019
    Publication date: July 22, 2021
    Inventors: Wen-Pin Chen, Mei-Hwan Wu, Hong-Nerng Ho
  • Viral protein
    Patent number: 7691390
    Abstract: The present invention is directed to an isolated polypeptide containing SEQ ID NO: 1 or an immunogenic fragment thereof. Also disclosed is an isolated nucleic acid encoding the polypeptide or containing a sequence at least 70% identical to SEQ ID NO: 3. Within the scope of this invention are related expression vectors, host cells, and antibodies. Also disclosed are methods of producing the polypeptide, diagnosing coronavirus infection, and identifying a test compound for treating coronavirus infection.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: April 6, 2010
    Inventors: Fang-Jen Lee, Chia-Jung Yu, Ming-Fu Chang, Hong-Nerng Ho
  • VIRAL PROTEIN
    Publication number: 20090068636
    Abstract: The present invention is directed to an isolated polypeptide containing SEQ ID NO: 1 or an immunogenic fragment thereof. Also disclosed is an isolated nucleic acid encoding the polypeptide or containing a sequence at least 70% identical to SEQ ID NO: 3. Within the scope of this invention are related expression vectors, host cells, and antibodies. Also disclosed are methods of producing the polypeptide, diagnosing coronavirus infection, and identifying a test compound for treating coronavirus infection.
    Type: Application
    Filed: September 19, 2007
    Publication date: March 12, 2009
    Inventors: Fang-Jen Lee, Chia-Jung Yu, Ming-Fu Chang, Hong-Nerng Ho